Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

138.21
+1.871.37%
Volume:2.62M
Turnover:362.85M
Market Cap:171.47B
PE:20.38
High:140.34
Open:137.71
Low:137.33
Close:136.34
52wk High:157.29
52wk Low:93.37
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.70
T/O Rate:0.21%
Dividend:3.16
Dividend Rate:2.29%
EPS(TTM):6.78
EPS(LYR):6.78
ROE:40.66%
ROA:12.52%
PB:7.55
PE(LYR):20.38

Loading ...

Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating

TIPRANKS
·
Feb 26

Gilead Says HIV Treatment Trial Results Show Efficacy

Dow Jones
·
Feb 26

Gilead presents new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data

TIPRANKS
·
Feb 26

Merck's New HIV Drug Shows Promise. Its Chief Medical Officer Explains Why Wall Street Should Care. -- Barrons.com

Dow Jones
·
Feb 26

Daiwa Securities Adjusts Price Target on Gilead Sciences to $161 From $129, Maintains Outperform Rating

MT Newswires Live
·
Feb 26

Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target

TIPRANKS
·
Feb 25

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 25

Gilead FY 2025 net income attributable to shareholders hits USD 8.5 billion (NM)

Reuters
·
Feb 25

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)

TIPRANKS
·
Feb 24

RPT-BREAKINGVIEWS-An $8 bln pharma deal prices patent fears

Reuters
·
Feb 24

Gilead Sciences (GILD) Receives a Buy from Scotiabank

TIPRANKS
·
Feb 24

Citi Reaffirms Their Buy Rating on Gilead Sciences (GILD)

TIPRANKS
·
Feb 24

CORRECTED-Belgium's Galapagos 2025 net revenue surges, driven by Gilead collaboration

Reuters
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)

TIPRANKS
·
Feb 24

Arcellx downgraded to Hold from Buy at Needham

TIPRANKS
·
Feb 23

Arcellx downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
Feb 23

Gilead Sciences Shares Down 0.8%

THOMSON REUTERS
·
Feb 23

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Renewed Trade Doubts

MT Newswires Live
·
Feb 23

Arcellx downgraded to Equal Weight from Overweight at Wells Fargo

TIPRANKS
·
Feb 23